<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">68371</article-id><article-id pub-id-type="doi">10.7554/eLife.68371</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-167776"><name><surname>Marie</surname><given-names>Isabelle J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231329"><name><surname>Brambilla</surname><given-names>Lara</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231331"><name><surname>Azzouz</surname><given-names>Doua</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231336"><name><surname>Chen</surname><given-names>Ze</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231339"><name><surname>Baracho</surname><given-names>Gisele V</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-167770"><name><surname>Arnett</surname><given-names>Azlann</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231337"><name><surname>Li</surname><given-names>Haiyan S</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231340"><name><surname>Liu</surname><given-names>Weiguo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231338"><name><surname>Cimmino</surname><given-names>Lluisa</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-226443"><name><surname>Chattopadhyay</surname><given-names>Pratip</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231330"><name><surname>Silverman</surname><given-names>Gregg</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-115144"><name><surname>Watowich</surname><given-names>Stephanie S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1969-659X</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167273"><name><surname>Khor</surname><given-names>Bernard</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4689-5092</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-230254"><name><surname>Levy</surname><given-names>David</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7320-7788</contrib-id><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Pathology</institution>, <institution>NYU School of Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Pathology and Medicine</institution>, <institution>NYU School of Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Medicine</institution>, <institution>NYU School of Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Immunology</institution>, <institution>BD Life Sciences</institution>, <addr-line><named-content content-type="city">La Jolla</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Translational Immunology</institution>, <institution>Benaroya Research Institute at Virginia Mason</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Immunology</institution>, <institution>MD Anderson</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Sylvester Comprehensive Cancer Center</institution>, <institution>University of Miami Miller School of Medicine</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Pathology and Microbiology</institution>, <institution>NYU School of Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-44759"><name><surname>Vance</surname><given-names>Russell E</given-names></name><role>Reviewing editor</role><aff><institution>University of California, Berkeley</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>Isabelle.Marie@nyulangone.org</email> (IM);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>david.levy@med.nyu.edu</email> (DL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>11</day><month>08</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e68371</elocation-id><history><date date-type="received"><day>13</day><month>03</month><year>2021</year></date><date date-type="accepted"><day>10</day><month>08</month><year>2021</year></date></history><permissions><copyright-statement>Â© 2021, Marie et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Marie et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-68371-v1.pdf"/><abstract><p>Maintenance of immune homeostasis involves a synergistic relationship between the host and the microbiome. Canonical interferon (IFN) signaling controls responses to acute microbial infection, through engagement of the STAT1 transcription factor. However, the contribution of tonic levels of IFN to immune homeostasis in absence of acute infection remains largely unexplored. We report that STAT1 KO mice spontaneously developed an inflammatory disease marked by myeloid hyperplasia and splenic accumulation of hematopoietic stem cells. Moreover, these animals developed inflammatory bowel disease. Profiling gut bacteria revealed a profound dysbiosis in absence of tonic IFN signaling, which triggered expansion of T<sub>H</sub>17 cells and loss of splenic T<sub>reg</sub> cells. Reduction of bacterial load by antibiotic treatment averted the T<sub>H</sub>17 bias, and blocking IL17 signaling prevented myeloid expansion and splenic stem cell accumulation. Thus, tonic IFNs regulate gut microbial ecology, which is crucial for maintaining physiologic immune homeostasis and preventing inflammation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>A!28900</award-id><principal-award-recipient><name><surname>Marie</surname><given-names>Isabelle J</given-names></name><name><surname>Levy</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>AI133822</award-id><principal-award-recipient><name><surname>Watowich</surname><given-names>Stephanie S</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>AR070591</award-id><principal-award-recipient><name><surname>Silverman</surname><given-names>Gregg</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>CA016087</award-id><principal-award-recipient><name><surname>Chattopadhyay</surname><given-names>Pratip</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Gisele V Baracho, Gisele Baracho is affiliated with BD Life Sciences. The author has no financial interests to declare.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animals used in these experiments were maintained in a single dedicated room of a specific pathogen-free vivarium at NYU Grossman School of Medicine. All work with experimental animals was in accordance with protocols approved by the NYU Langone Health Institutional Animal Care and Use Committee (IACUC ID: IA16-01579).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data related to microbiome analysis have been deposited in Dryad at http://dx.doi.org/10.5061/dryad.b5mkkwhcvSource data files for other figures are provided with the manuscript.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Levy</collab><collab>Marie</collab><collab>Chen</collab><collab>Silverman</collab><collab>Azzouz</collab></person-group><year iso-8601-date="2021">2021</year><source>Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome, Dryad, Dataset</source><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.b5mkkwhcv">http://dx.doi.org/10.5061/dryad.b5mkkwhcv</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.b5mkkwhcv</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-68371-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>